Company intelligence / Profile preview

Verthermia

Nevada, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Phase 1 clinical trials ongoing for ovarian cancer treatment using whole body hyperthermia. A case study showed an elderly female with recurrent metastatic peritoneal serous papillary carcinoma achieved stable disease after six HEATT cycles, followed by successful chemotherapy resulting in no evidence of disease for nine months with 27-month survival

Therapeutic areas: OncologyInfectious Diseases
Modalities: DeviceHyperthermia therapy
Industry: Therapeutic Medical Devices

Partnerships

First Baptist Medical Center

Beyond the preview

Go deeper on Verthermia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verthermia.

Explore the full profile